» Articles » PMID: 18945841

Molecular Epidemiology and Phylogenetic Distribution of the Escherichia Coli Pks Genomic Island

Overview
Specialty Microbiology
Date 2008 Oct 24
PMID 18945841
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiological and phylogenetic associations of the pks genomic island of extraintestinal pathogenic Escherichia coli (ExPEC), which encodes the genotoxin colibactin, are incompletely defined. clbB and clbN (as markers for the 5' and 3' regions of the pks island, respectively), clbA and clbQ (as supplemental pks island markers), and 12 other putative ExPEC virulence genes were newly sought by PCR among 131 published E. coli isolates from hospitalized veterans (62 blood isolates and 69 fecal isolates). Blood and fecal isolates and clbB-positive and -negative isolates were compared for 66 newly and previously assessed traits. Among the 14 newly sought traits, clbB and clbN (colibactin polyketide synthesis system), hra (heat-resistant agglutinin), and vat (vacuolating toxin) were significantly associated with bacteremia. clbB and clbN identified a subset within phylogenetic group B2 with extremely high virulence scores and a high proportion of blood isolates. However, by multivariable analysis, other traits were more predictive of blood source than clbB and clbN were; indeed, among the newly sought traits, only pic significantly predicted bacteremia (negative association). By correspondence analysis, clbB and clbN were closely associated with group B2 and multiple B2-associated traits; by principal coordinate analysis, clbB and clbN partitioned the data set better than did blood versus fecal source. Thus, the pks island was significantly associated with bacteremia, multiple ExPEC-associated virulence genes, and group B2, and within group B2, it identified an especially high-virulence subset. This extends previous work regarding the pks island and supports investigation of the colibactin system as a potential therapeutic target.

Citing Articles

Synthesis, Antimicrobial Activity, and Tyrosinase Inhibition by Multifunctional 3,4-Dihydroxy-Phenyl Peptidomimetics.

Wavhal D, Koszelewski D, Kowalczyk P, Brodzka A, Ostaszewski R Int J Mol Sci. 2025; 26(4).

PMID: 40004165 PMC: 11855086. DOI: 10.3390/ijms26041702.


Genomic characterization of Escherichia coli with a polyketide synthase (pks) island isolated from ulcerative colitis patients.

Lv C, Abdullah M, Su C, Chen W, Zhou N, Cheng Z BMC Genomics. 2025; 26(1):19.

PMID: 39780077 PMC: 11707995. DOI: 10.1186/s12864-024-11198-x.


Microbiota-derived small molecule genotoxins: host interactions and ecological impact in the gut ecosystem.

Zechner E, Kienesberger S Gut Microbes. 2024; 16(1):2430423.

PMID: 39558480 PMC: 11581169. DOI: 10.1080/19490976.2024.2430423.


A flow cytometry method for quantitative measurement and molecular investigation of the adhesion of bacteria to yeast cells.

Schiavone M, Dagkesamanskaya A, Vieu P, Duperray M, Duplan-Eche V, Francois J Sci Rep. 2024; 14(1):20935.

PMID: 39251857 PMC: 11385505. DOI: 10.1038/s41598-024-72030-w.


Analysis of the partial sequencing of clbA, clbB and clbQ in Escherichia coli isolates that produce colibactin and multilocus sequence typing.

Dhahi M Sci Rep. 2024; 14(1):17966.

PMID: 39095472 PMC: 11297330. DOI: 10.1038/s41598-024-68867-w.


References
1.
Johnson J, Stell A, Scheutz F, OBryan T, Russo T, Carlino U . Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay. Infect Immun. 2000; 68(3):1587-99. PMC: 97319. DOI: 10.1128/IAI.68.3.1587-1599.2000. View

2.
Johnson J, Stell A . Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 1999; 181(1):261-72. DOI: 10.1086/315217. View

3.
Nowrouzian F, Adlerberth I, Wold A . P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli. Epidemiol Infect. 2001; 126(1):11-8. PMC: 2869660. DOI: 10.1017/s0950268801005118. View

4.
Russo T, Johnson J . Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003; 5(5):449-56. DOI: 10.1016/s1286-4579(03)00049-2. View

5.
Johnson J, Gajewski A, Lesse A, Russo T . Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol. 2003; 41(12):5798-802. PMC: 309005. DOI: 10.1128/JCM.41.12.5798-5802.2003. View